Company Analysis

GlucoTrack, Inc. GCTK

A comprehensive view of key metrics, scores, and financial health for GlucoTrack, Inc.

Overview of GlucoTrack, Inc.

GCTK NCM

Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Micro Cap

GlucoTrack, Inc. (GCTK), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $1.61, about 0.0% overvalued vs fair value, -98.5% 1Y return, ranked 1130/1145 in sector.

Metrics ROE 381.2%

USD 1.61

99.75%

(Delayed)

• Vol 90d: 275.3%

52-Week Range

Low

0.60

Now 1.61

High

109.50

Market Cap

$321,812

Enterprise Value

$1.14M

Overall Score

View breakdown

Overall

Growth

Weak

Profitability

Weak

Health

Weak

Efficiency

Weak

Valuation

Weak

Growth

Weak

Profitability

Weak

Health

Weak

Efficiency

Weak

Valuation

Weak

Completeness: 76%

Confidence: 82%

Updated: Oct 24

Top Beats

No strong beats yet

Quick Facts

Website https://glucotrack.com

HQ Rutherford, NJ

Employees 11

Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data

Show more details

Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps

Total Revenue

Free Cash Flow

-$15.3M

-21.8%%

Money Flow Bridge

You are currently seeing a limited view of the money flow waterfall.

See the full waterfall with all stages on Premium. Upgrade

Flow Direction: Money moves from left to right

Components: Breakdown shows composition of each stage

Industry-Specific: Medical Devices & Diagnostics

Data Quality Notes

Operating income uses OperatingIncome because as-reported operating income is unavailable. It can exclude one-off charges, so it may not reconcile with GAAP net income.
Note: 'FCF Conversion' (FCF / Net Income) often exceeds 100% for MedTech companies. This is expected and desirable — M&A intangible amortisation depresses GAAP net income without consuming cash, making FCF the truer owner earnings proxy.

Quality & Reliability Indicators

FCF Conversion

79%

Free Cash Flow / Net Income — not meaningful while net income is negative

Locked Metric

Premium

Where It Leaks

Cash Flow Health critical

Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.

Active Leaks

1/1

Improving

High Impact

Critical

Interest Drag

Current: -23.2x

Allocation Leak

Improving

Scores based on quantitative metrics and qualitative factors

Full moat analysis

Key risks

Weak Capital Return Profile Capital return quality is below peers (score 0.02). Low ROIC raises questions about M&A discipline and pipeline ROI.
Thin Interest Coverage Interest coverage lags peers (score 0.30). Thin coverage limits M&A optionality and raises refinancing risk.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Insufficient Data

—

Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

R&D Pipeline & Capital Returns

Weak

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

FCF Quality & Cash Conversion

Insufficient Data

—

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Commercial Execution

Insufficient Data

—

Premium

Signals, strengths and risks for Commercial Execution

Capital Structure & Resilience

Developing

Premium

Signals, strengths and risks for Capital Structure & Resilience

Growth Durability

Weak

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger

Where management spends the performance budget

Insufficient Data for Analysis

GCTK - GlucoTrack, Inc.

We have limited financial data for GCTK. The Growth and Profitability axes don't have enough metrics for reliable analysis.

Data Coverage by Axis

Growth

25% coverage Below threshold

Profitability

23% coverage Below threshold

Overall Coverage: 36.0% (Minimum 40% required)

What This Means

Currently at 36.0% data coverage (minimum 40% required)
Check back after quarterly or annual filings
Some metrics may not be applicable to this company's business model

What can you do?

View available sections like Moat Map or Engine Room for partial insights
Set up a watchlist alert to be notified when new data becomes available
Compare with peers in the same industry that have complete data

Two Futures

Scenario-based fair value ranges for GlucoTrack, Inc..

WACC X.X%

X%XX%

Rev CAGR 5Y X.X%

-XX%XX%

Op Margin XX.X%

-XX%XX%

Adjust the sliders above to explore different valuation scenarios.

Unlock Premium

Reveal the full Scenario Theatre

See live sliders, narratives, and full Bear/Base/Bull outcomes.

Upgrade Now

Bear

- - -

- upside

Base

- - -

- upside

Bull

- - -

- upside

Fair Value Range Current: $-

$- $- $-

GlucoTrack, Inc. GCTK

Overview of GlucoTrack, Inc.

Quick Facts

Next Events

Fair Value Snapshot

Engine Room Money Flow™

Flow Steps

Money Flow Bridge

Data Quality Notes

Quality & Reliability Indicators

FCF Conversion

Locked Metric

Where It Leaks

Interest Drag

Key Metrics

Competitive Advantage Assessment

Key risks

Unlock full defense analysis

Pricing Power & Consumable Moat

R&D Pipeline & Capital Returns

FCF Quality & Cash Conversion

Commercial Execution

Capital Structure & Resilience

Growth Durability

Trade-Off Ledger

Insufficient Data for Analysis

Data Coverage by Axis

What This Means

Two Futures

Actions & Info

Send Feedback